Cargando…

Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most fatal cancers in the world. There is an urgent need to understand the molecular background of HCC to facilitate the identification of biomarkers and discover effective therapeutic targets. Published transcriptomic studies have reported a large number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yongjun, Zhang, Heping, Xu, Yuqing, Liu, Yao-Zhong, Al-Adra, David P, Yeh, Matthew M, Zhang, Zhengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413891/ https://www.ncbi.nlm.nih.gov/pubmed/37577174 http://dx.doi.org/10.1177/11769351231190477

Ejemplares similares

RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature
por: Liu, Yongjun, et al.
Publicado: (2022)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Long, Jianting, et al.
Publicado: (2022)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Genomic Transcriptome Benefits and Potential Harms of COVID-19 Vaccines Indicated from Optimized Genomic Biomarkers
por: Zhang, Zhengjun
Publicado: (2022)

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

HBO1 overexpression is important for hepatocellular carcinoma cell growth
por: Zhong, Wenhui, et al.
Publicado: (2021)

Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
por: Nath, Lekshmi R, et al.
Publicado: (2021)

Biomarkers for Hepatocellular Carcinoma
por: Lou, Jiatao, et al.
Publicado: (2017)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Elevated FAM134B expression induces radiation-sensitive in hepatocellular carcinoma
por: Xie, Binhui, et al.
Publicado: (2023)

Optimization Design and Performance Analysis of a Bionic Knee Joint Based on the Geared Five-Bar Mechanism
por: Wang, Zhuo, et al.
Publicado: (2023)

Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer
por: Huang, Zuoliang, et al.
Publicado: (2018)

Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma
por: Chen, Chao, et al.
Publicado: (2021)

A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Tian, Dazhi, et al.
Publicado: (2021)

LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β-Catenin in the Nucleus to Augment Wnt Signaling
por: Peng, Liang, et al.
Publicado: (2022)

A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
por: Wang, Zeyu, et al.
Publicado: (2020)

Bioinformatics Profiling of Five Immune-Related lncRNAs for a Prognostic Model of Hepatocellular Carcinoma
por: Wu, Fahong, et al.
Publicado: (2021)

Lift the Veil of Breast Cancers Using 4 or Fewer Critical Genes
por: Zhang, Zhengjun
Publicado: (2022)

Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Feng, et al.
Publicado: (2021)

A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Optimization of Thumb Prosthesis Design by Using Five Performance Criteria
por: Tsamo, Nestor, et al.
Publicado: (2022)

GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021)

Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma
por: Li, Lingli, et al.
Publicado: (2021)

Gastrointestinal Biomarkers and Their Association with Feeding in the First Five Days of Pediatric Critical Illness
por: Veldscholte, Karlien, et al.
Publicado: (2023)

Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis
por: Liu, Defu, et al.
Publicado: (2022)

GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5
por: Fu, Binsheng, et al.
Publicado: (2016)

Biomarkers for Hepatocellular Carcinoma
por: Behne, Tara, et al.
Publicado: (2012)

Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma
por: Hu, Rui, et al.
Publicado: (2023)

Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7
por: Lin, Yixiong, et al.
Publicado: (2017)

Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma
por: Zhang, Kefen, et al.
Publicado: (2022)

Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma
por: Yao, Min, et al.
Publicado: (2014)

NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
por: Zou, Wenshuang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hhlstm4ub2253qlfjmuj255p6